AzTrials
AzTrials

MeditationNCT04272138

A Brief App-based Mobile Health and Well-being Intervention Among Middle-aged Adults

A study testing Calm Meditation in people with Meditation and Control Group, run by Arizona State University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine the preliminary effects of using a mobile app (i.e., Calm) to decrease overall stress in middle-aged (i.e., 40-64 years) men and women who report high stress (greater than 15 on PSS). Read more about this study

Who is it for?
Ages 40 to 64 yearsHealthy volunteers can take part
Conditions the study is for
Meditation, Control Group
What is being tested?
Calm Meditation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
83 participants
Where
1 siteUnited States
Study dates
3 Feb 2020to 16 Jun 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 64 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Men or Women
  • Age 40-64
  • Able to read/understand English
  • Have access to a smartphone on a daily basis
  • A score of 15 or higher on the Perceived Stress Scale (PSS)
  • Willing to be randomized
  • Willing to download a mobile application

Who cannot join

  • Have consistently practiced mindfulness meditation within the last 12 months
  • Currently using the Calm app or another meditation app
  • Currently prescribed mental health or mood medication
  • Low levels of stress (i.e., less than a score of 15 assessed with the Perceived Stress Scale)
  • Currently reside outside the United States

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Arizona Biomedical Collaborative

    Phoenix, Arizona, 85004

Other trials in United States

About this study

Official title: Feasibility of Using a Mobile App (i.e., Calm) to Decrease Overall Stress in Middle-aged (i.e., 40-64 Years) Men and Women Who Report High Stress (>15 on PSS)

The purpose of this study is to determine the preliminary effects of using a mobile app (i.e., Calm) to decrease overall stress in middle-aged (i.e., 40-64 years) men and women who report high stress (greater than 15 on PSS).

The study design is a randomized control trial with baseline, post-intervention (4 weeks from baseline), and follow-up phone interview (5 weeks from baseline) assessments. Middle-aged adults will be randomized to either a Calm meditation Intervention group or an attention control podcast group. Participants will be randomized after the completion of baseline and informed consent.

Read more

Specific aim 1: Determine the feasibility (acceptability, demand) of using CALM app at least 10 min/day to reduce stress (greater than 15 on Perceived Stress Scale [PSS]) in middle-aged men and women.

Benchmarks for feasibility: (acceptability) Recruitment greater than 40 percent men; greater than 75 percent satisfied with intervention; 75 percent perceive daily meditation and app components as appropriate and useful; (demand) Retention of men greater than 75 percent; greater than 80 percent adherence (minutes/week) to the meditation intervention.

Specific aim 2: Explore the preliminary effect of meditation using Calm on overall perceived stress as compared to the health education group.

Specific aim 3: Explore the preliminary effect of meditation using Calm on anxiety and depression.

Specific aim 4: Explore gender as a moderator of the effect of meditation using Calm on stress.

Specific aim 5: Explore the mediators of mindfulness, physical activity, eating, and coping behaviors on stress, anxiety and depression using Calm for meditation.

Read the detailed description

Recruitment: Participants will be recruited during winter/spring 2020. Interested participants will be directed to a REDCap link to complete an online eligibility screener. The screener will take approximately 10 minutes to complete (See Eligibility Survey). The survey will be free, voluntary, and available online. Participants will be allowed to skip questions in the survey.

Eligibility: Once eligibility is determined; participants will be sent an informed consent and baseline questionnaire via a REDCap link. This measure should take approximately 25 minutes to complete (See Informed Consent and Baseline Questionnaires). Once Informed Consent is signed and the Baseline Questionnaires are complete, participants will be randomized via an online randomizer (i.e., randomizer.com) to either an attention control podcast group or the Calm meditation group. Ineligible participants will be sent an email notifying their status and why.

Enrollment: The Research Team will email the intervention participants that will include instructions to download Calm (See Participant Scripts). The control participants will be emailed instructions to download the podcast app (See Participant Scripts).

Intervention: The intervention will run for 4-weeks. Intervention participants will complete the 30 day, "How to Meditate" meditation series that provides daily 10-minute meditations and the control group will listen to daily 10-minute health education podcasts. Throughout the intervention, both groups will be sent reminder emails via REDCap to participate in their assigned practice sessions (see Participant Scripts) participants will complete online weekly participation logs via REDCap. Additionally, they will answer one, multiple choice EMA (ecological momentary assessment) question, randomly, 3x per day (between 8am and 8pm) via test message assessing how one currently feels (see Study Questionnaires).

Tracking: Participation in the Calm meditations will be tracked (meditation name, time of day, and time spent in meditation) by weekly REDCap participation logs and the Calm team.

Post-intervention: Post-intervention questionnaires and the satisfaction survey will be emailed to intervention and control participants via a link from REDCap (See Post-intervention questionnaires). The post-intervention survey will take about 25 minutes and the satisfaction survey will take about 10 minutes.

Post-intervention interview: Post-intervention phone interviews will be conducted the week following the end of the intervention (week 5) to no more than 20 participants in each group and take about 15-20 minutes.

Being tested
Calm Meditation, Educational Podcast Control

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Calm MeditationBehavioural

    The intervention will run for 4-weeks. Participants will complete the 30 day, "How to Meditate" meditation series that provides daily 10-minute meditations. Throughout the intervention, participants will be sent reminder emails via REDCap to participate in their assigned practice sessions participants and will complete online weekly participation logs via REDCap. Additionally, they will answer one, multiple-choice ecological momentary assessment question, randomly, 3x per day via test message assessing how one currently feels. Participants will complete baseline and post-intervention measures of the Perceived Stress Scale, Hospital Anxiety and Depression Scale, Mindfulness Attention Awareness Scale, International Physical Activity Questionnaire, Salzberg Stress Eating Scale, Brief Cope, and Brief Resilience Scale. Following these measures, participants will be asked to complete a satisfaction questionnaire (week 5) and have the opportunity to volunteer for a short phone interview.

  • Educational Podcast ControlBehavioural

    The intervention will run for 4-weeks. Control group participants will listen to daily 10-minute health education podcasts. Throughout the intervention, participants will be sent reminder emails via REDCap to participate in their assigned practice sessions and participants will complete online weekly participation logs via REDCap. Additionally, they will answer one, multiple-choice EMA (ecological momentary assessment) question, randomly, 3x per day via test message assessing how one currently feels. Participants will complete baseline and post-intervention measures of the Perceived Stress Scale, Hospital Anxiety and Depression Scale, Mindfulness Attention Awareness Scale, International Physical Activity Questionnaire, Salzberg Stress Eating Scale, Brief Cope, and Brief Resilience Scale. Following these measures, participants will be asked to complete a satisfaction questionnaire (week 5) and have the opportunity to volunteer for a short phone interview.

Study groups in NCT04272138
Study groupRoleWhat they receive
Calm MeditationExperimentalParticipants in the intervention group will be exposed to 10 minutes per day of meditation via a smartphone application for 4 weeks. Participants will log their meditation participation in an online weekly log.
Receives: Behavioral: Calm Meditation
Educational Podcast ControlActive comparatorParticipants in the control group will be exposed to 10 minutes per day of health education podcasts via a smartphone application for 4 weeks. Participants will log their podcast participation in an online weekly log.
Receives: Behavioral: Educational Podcast Control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility: Acceptability

    Acceptability will be measured using a satisfaction survey at the end of the study, following all other measures (satisfied with the intervention and perceive daily meditation and app components as appropriate and useful)

    Measured: Measured 1x at post-intervention about experience in study, about 4 weeks.

  2. Feasibility: Demand

    Demand will be measured using the subjective usage data (weekly participation logs measuring adherence (minutes/week) and the objective app usage data (data collected by the app measuring adherence (minutes/week) to the meditation intervention).

    Measured: 1x at post-intervention about participation time in study (4 weeks total)

Secondary outcomes (9)
  1. Stress

    Stress will be measured using the Perceived Stress Scale -10 item, with scores ranging from 10-40) and a higher score indicates a worse outcome.

    Measured: Change from baseline (week 0) to post-intervention (week 4)

  2. Anxiety

    Anxiety will be measured using the Hospital Anxiety and Depression Scale, with scores ranging from 0-21, and a higher score indicates a worse outcome.

    Measured: Change from baseline (week 0) to post-intervention (week 4)

  3. Depression

    Depression will be measured using the Hospital Anxiety and Depression Scale, with scores ranging from 0-21, and a higher score indicates a worse outcome.

    Measured: Change from baseline (week 0) to post-intervention (week 4)

  4. Gender as moderator of stress

    Self-reported gender

    Measured: Change from baseline (week 0) to post-intervention (week 4)

  5. Mindfulness as a mediator of stress

    Mindfulness will be measured using the Mindful Attention Awareness Scale, with scores ranging from 15-90, and a higher score indicates a better outcome.

    Measured: Change from baseline (week 0) to post-intervention (week 4)

  6. Physical Activity as a mediator on stress, anxiety, and depression

    Physical activity will be measured using the International Physical Activity Questionnaire, when a higher score indicates a better outcome.

    Measured: Change from baseline (week 0) to post-intervention (week 4)

  7. Eating as a mediator on stress, anxiety, and depression

    Eating will be measured using the Salzburg Stress Eating Scale, with scores ranging from 5-100, and a higher score indicates a worse outcome.

    Measured: Change from baseline (week 0) to post-intervention (week 4)

  8. Coping behaviors as a mediator on stress, anxiety, and depression

    Coping behaviors will be measured using the Brief COPE Inventory, with scores ranging from 2-8, and a higher score indicates a better outcome.

    Measured: Change from baseline (week 0) to post-intervention (week 4)

  9. Resilience

    Resilience will be measured using the Brief Resilience Scale, with scores ranging from 1-5, and a higher score indicates a better outcome.

    Measured: Change from baseline (week 0) to post-intervention (week 4)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Feb 2020
  2. Study start3 Feb 2020
  3. Primary completion18 May 2020
  4. Study completion16 Jun 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
83 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04272138
Sponsor's protocol ID
STUDY00011219
Status last verified
Feb 2022
First submitted
13 Jan 2020
Last updated
28 Feb 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Laird B, Puzia M, Larkey L, Ehlers D, Huberty J. A Mobile App for Stress Management in Middle-Aged Men and Women (Calm): Feasibility Randomized Controlled Trial. JMIR Form Res. 2022 May 24;6(5):e30294. doi: 10.2196/30294.

    PubMed 34989677

Questions about this trial

What is this clinical trial studying?

A study testing Calm Meditation in people with Meditation and Control Group, run by Arizona State University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Feb 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility: Acceptability (time frame: Measured 1x at post-intervention about experience in study, about 4 weeks.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04272138, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Feb 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in